2Lim YS,Kim WR.The global impact of hepatic fibrosis and end stage liver disease.Clin Liver Dis,2008,12:733-746.
3Everhart JE,Ruhl CE.Burden of digestive diseases in the United States Part Ⅲ:liver,biliary tract,and pancreas.Gastroenterology,2009,136:1134-1144.
4Browning JD,Szczepaniak LS,Dobbins R,et al.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology,2004,40:1387-1395.
6D'Souza RD,Glynn MJ,Ushiro-Lumb I,et al.Prevalence of hepatitis C cirrhosis in elderly Asian patients infected during childhood.Clin Gastroenterol Hepatol,2005,3:910-917.
7Seeff LB,Everhart JE.Is cirrhosis an inevitable consequence of chronic hepatitis C virus infection- Clin Gastroenterol Hepatol,2005,3:840-842.
8Poynard R,Ratziu V,Charlotte R,etal.Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C.J Hepatol,2001,34:730-739.
9Seeff LB.Natural history of chronic hepatitis C.Hepatology,2002,36(5 Suppl 1):S35-S46.
10Davis GL,Alter MJ,El-Serag H,et al.Aging of the hepatitis C virus infected persons in the United States:a multiple cohort model of HCV prevalence and disease progression.Gastroenterology,2010,138:513-521.
6UENO T, HASHIMOTO O, KIMURA R, et al. Relation of type Ⅱ trans-forming growth factor-beta receptrto hepatic fibrosis and hepatocellular carcinoma [ J]. Int J Oncol,2001,18:49.
